Compared to Estimates, Avantor (AVTR) Q1 Earnings: A Look at Key Metrics

Zacks
04-25

Avantor, Inc. (AVTR) reported $1.58 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 5.9%. EPS of $0.23 for the same period compares to $0.22 a year ago.

The reported revenue represents a surprise of -1.72% over the Zacks Consensus Estimate of $1.61 billion. With the consensus EPS estimate being $0.23, the company has not delivered EPS surprise.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Avantor performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenue- Bioscience Production: $516.40 million versus the four-analyst average estimate of $530.71 million.
  • Revenue- Laboratory Solutions: $1.07 billion compared to the $1.09 billion average estimate based on four analysts.
  • Adjusted Operating Income- Laboratory Solutions: $139 million versus $128.24 million estimated by two analysts on average.
  • Adjusted Operating Income- Corporate: -$19.60 million compared to the -$14.91 million average estimate based on two analysts.
  • Adjusted Operating Income- Bioscience Production: $123.40 million compared to the $121.23 million average estimate based on two analysts.
View all Key Company Metrics for Avantor here>>>

Shares of Avantor have returned -4.1% over the past month versus the Zacks S&P 500 composite's -4.8% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Avantor, Inc. (AVTR) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10